TransUnion 4
4 · TransUnion · Filed May 17, 2017
Insider Transaction Report
Form 4
TransUnionTRU
McCarthy Gerald M JR
EVP - Healthcare
Transactions
- Sale
Common Stock
2017-05-16$41.68/sh−73,500$3,063,480→ 29,061 total - Exercise/Conversion
Common Stock
2017-05-16$13.06/sh+73,500$959,910→ 102,561 total - Exercise/Conversion
Stock Options (right to buy)
2017-05-16$13.06/sh−73,500$959,910→ 174,837 totalExercise: $13.06Exp: 2024-07-01→ Common Stock (73,500 underlying)
Footnotes (2)
- [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.52 to $41.76, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Represents an initial grant of 248,337 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017. The time-based vesting criteria is satisfied as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter.